These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9129781

  • 1. Neuroleptic binding to sigma receptors: possible involvement in neuroleptic-induced acute dystonia.
    Jeanjean AP, Laterre EC, Maloteaux JM.
    Biol Psychiatry; 1997 May 15; 41(10):1010-9. PubMed ID: 9129781
    [Abstract] [Full Text] [Related]

  • 2. BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
    Okumura K, Ujike H, Akiyama K, Kuroda S.
    J Neural Transm (Vienna); 1996 May 15; 103(10):1153-61. PubMed ID: 9013402
    [Abstract] [Full Text] [Related]

  • 3. Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus.
    Yoshida K, Takahashi H, Sato K, Higuchi H, Shimizu T.
    Pharmacol Biochem Behav; 2000 Nov 15; 67(3):497-500. PubMed ID: 11164078
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB.
    J Pharmacol Exp Ther; 1988 Mar 15; 244(3):987-93. PubMed ID: 2908050
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
    Hayashi T, Su TP, Kagaya A, Nishida A, Shimizu M, Yamawaki S.
    Synapse; 1999 Jan 15; 31(1):20-8. PubMed ID: 10025680
    [Abstract] [Full Text] [Related]

  • 6. Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions.
    Matsumoto RR, Pouw B.
    Eur J Pharmacol; 2000 Aug 04; 401(2):155-60. PubMed ID: 10924920
    [Abstract] [Full Text] [Related]

  • 7. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
    Bylund DB.
    J Pharmacol Exp Ther; 1981 Apr 04; 217(1):81-6. PubMed ID: 6110776
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
    Takahashi S, Sonehara K, Takagi K, Miwa T, Horikomi K, Mita N, Nagase H, Iizuka K, Sakai K.
    Psychopharmacology (Berl); 1999 Aug 04; 145(3):295-302. PubMed ID: 10494578
    [Abstract] [Full Text] [Related]

  • 9. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.
    Loonen AJ, Ivanova SA.
    J Psychopharmacol; 2021 Jan 04; 35(1):3-14. PubMed ID: 32900259
    [Abstract] [Full Text] [Related]

  • 10. Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage.
    Seeman P.
    Acta Psychiatr Scand Suppl; 1990 Jan 04; 358():14-20. PubMed ID: 1978482
    [Abstract] [Full Text] [Related]

  • 11. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb 04; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 12. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
    Inoue A, Miki S, Seto M, Kikuchi T, Morita S, Ueda H, Misu Y, Nakata Y.
    Eur J Pharmacol; 1997 Feb 19; 321(1):105-11. PubMed ID: 9083792
    [Abstract] [Full Text] [Related]

  • 13. Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
    Ohno Y, Ishida-Tokuda K, Ishibashi T, Nakamura M.
    Pharmacol Biochem Behav; 1997 Aug 19; 57(4):889-95. PubMed ID: 9259021
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and preliminary evaluation of [123I]1-(4-cyanobenzyl)-4-[[(trans-iodopropen-2-yl)oxy]meth yl]piperidin e: a novel high affinity sigma receptor radioligand for SPECT.
    Waterhouse RN, Mardon K, O'Brien JC.
    Nucl Med Biol; 1997 Jan 19; 24(1):45-51. PubMed ID: 9080474
    [Abstract] [Full Text] [Related]

  • 15. Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats.
    Tran TT, de Costa BR, Matsumoto RR.
    Psychopharmacology (Berl); 1998 May 19; 137(2):191-200. PubMed ID: 9630006
    [Abstract] [Full Text] [Related]

  • 16. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
    Leysen JE, Gommeren W, Mertens J, Luyten WH, Pauwels PJ, Ewert M, Seeburg P.
    Psychopharmacology (Berl); 1993 May 19; 110(1-2):27-36. PubMed ID: 7870895
    [Abstract] [Full Text] [Related]

  • 17. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.
    Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR.
    Eur J Pharmacol; 1995 Jul 14; 280(3):301-10. PubMed ID: 8566098
    [Abstract] [Full Text] [Related]

  • 18. Novel piperidine sigma receptor ligands as potential antipsychotic drugs.
    Gilligan PJ, Cain GA, Christos TE, Cook L, Drummond S, Johnson AL, Kergaye AA, McElroy JF, Rohrbach KW, Schmidt WK.
    J Med Chem; 1992 Nov 13; 35(23):4344-61. PubMed ID: 1360026
    [Abstract] [Full Text] [Related]

  • 19. N-(1-arylpropionyl)-4-aryltetrahydropyridines, a new class of high-affinity selective sigma receptor ligands.
    Schuster DI, Pan YP, Singh G, Stoupakis G, Cai B, Lem G, Ehrlich GK, Frietze W, Murphy RB.
    J Med Chem; 1993 Nov 26; 36(24):3923-8. PubMed ID: 7902869
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
    Waddington JL, Cross AJ, Gamble SJ, Bourne RC.
    Adv Biochem Psychopharmacol; 1983 Nov 26; 37():299-308. PubMed ID: 6138952
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.